Cargando...
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous anticoagulant therapies. DOACs directly, selectively, and reversibly inhibit factors IIa or Xa. The coagulation effect foll...
Gardado en:
| Publicado en: | Biomedicines |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8143174/ https://ncbi.nlm.nih.gov/pubmed/33919121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9050445 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|